Booz Allen Hamilton (BAH)
NYSE: BAH
· Real-Time Price · USD
103.19
1.05 (1.03%)
At close: Jun 06, 2025, 3:59 PM
103.55
0.34%
After-hours: Jun 06, 2025, 05:48 PM EDT
Booz Allen Hamilton Revenue Breakdown
Period Ending | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 |
---|---|---|---|---|---|---|---|
Cost Reimbursable Contract Revenue | 6.87B | 5.87B | 4.91B | 4.51B | 4.42B | 4.21B | 3.58B |
Cost Reimbursable Contract Revenue Growth | +16.89% | +19.65% | +8.73% | +2.14% | +4.94% | +17.62% | n/a |
Fixed-price Contract Revenue | 2.41B | 2.26B | 2.05B | 1.83B | 1.48B | 1.51B | 1.55B |
Fixed-price Contract Revenue Growth | +6.62% | +9.98% | +12.07% | +24.11% | -2.54% | -2.06% | n/a |
Time-and-materials Contract Revenue | 2.71B | 2.53B | 2.3B | 2.02B | 1.96B | 1.74B | 1.58B |
Time-and-materials Contract Revenue Growth | +6.98% | +10.16% | +13.87% | +2.76% | +12.98% | +10.19% | n/a |
Revenue by Geography
Period Ending | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 |
---|---|---|---|---|---|---|
United States Revenue | 10.49B | 9.03B | 8.15B | 7.66B | 7.2B | 6.44B |
United States Revenue Growth | +16.16% | +10.82% | +6.43% | +6.29% | +11.79% | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 349.68M | 341.63M | 225.42M | 329.29M | 366.28M | 300.27M | 300.89M | 314M | 563.85M | 422.39M | 293.61M | 253.06M | 332.38M | 262.61M | 262.26M | 301.8M | 291.46M | 254.82M | 244.7M | 245.85M | 311.84M | 245.72M | 244.12M | 234.28M | 272.53M | 222.67M | 226.9M | 205.84M | 245.2M | 203.95M | 213.62M | 193.44M | 232.09M | 201.18M | 194.46M | 189.7M | 208.9M | 200.81M | 208.14M | 188.66M | 228.54M |
Selling, General, and Administrative Revenue Growth | +2.36% | +51.55% | -31.54% | -10.10% | +21.98% | -0.20% | -4.18% | -44.31% | +33.49% | +43.86% | +16.02% | -23.86% | +26.57% | +0.13% | -13.10% | +3.55% | +14.38% | +4.14% | -0.47% | -21.16% | +26.91% | +0.65% | +4.20% | -14.03% | +22.39% | -1.86% | +10.23% | -16.05% | +20.23% | -4.53% | +10.43% | -16.65% | +15.36% | +3.46% | +2.51% | -9.19% | +4.03% | -3.52% | +10.33% | -17.45% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |